Pomegranate protection against cardiovascular diseases

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Aviram, Michael ^a   Rosenblat, Mira ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; FLAVONOID; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYPHENOL; TRIACYLGLYCEROL;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; FOAM CELL; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; PRIORITY JOURNAL;

EID: 84871395105     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/382763     Document Type: Article

References (70)

1. Rice-Evans C. A., Miller N. J., Bolwell P. G., Bramley P. M., Pridham J. B., The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radical Research 1995 22 4 375 383 2-s2.0-0028999867
2. Van Acker S. A. B. E., Van Den Berg D. J., Tromp M. N. J. L., Griffioen D. H., Van Bennekom W. P., Van Der Vijgh W. J. F., Bast A., Structural aspects of antioxidant activity of flavonoids. Free Radical Biology and Medicine 1996 20 3 331 342 2-s2.0-0029921813 10.1016/0891-5849(95)02047-0 (Pubitemid 26077855)
3. Fuhrman B., Aviram M., Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Current Opinion in Lipidology 2001 12 1 41 48 2-s2.0-0035140416 10.1097/00041433-200102000-00008 (Pubitemid 32121284)
4. Fuhrman B., Aviram M., Cadenas E., Packer L., Polyphenols and flavonoids protect LDL against atherogenic modifications. Handbook of Antioxidants Biochemical, Nutritional and Clinical Aspects 2001 16 2nd NY, USA Marcel Dekker 303
5. Rosenblat M., Belinky P., Vaya J., Levy R., Hayek T., Coleman R., Merchav S., Aviram M., Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. Journal of Biological Chemistry 1999 274 20 13790 13799 2-s2.0-0033553495 10.1074/jbc.274.20.13790 (Pubitemid 29228014)
6. Hertog M. G. L., Kromhout D., Aravanis C., Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 1995 155 4 381 386 10.1001/archinte.1995. 00430040053006
7. Knekt P., Kumpulainen J., Järvinen R., Rissanen H., Heliövaara M., Reunanen A., Hakulinen T., Aromaa A., Flavonoid intake and risk of chronic diseases. American Journal of Clinical Nutrition 2002 76 3 560 568 2-s2.0-0036721149 (Pubitemid 34920833)
8. Knekt P., Järvinen R., Reunanen A., Maatela J., Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal 1996 312 7029 478 481 2-s2.0-0030068760 (Pubitemid 26061237)
9. Renaud S., De Lorgeril M., Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992 339 8808 1523 1526 2-s2.0-0026651085 10.1016/0140-6736(92)91277-F
10. Aviram M., Antioxidants in restenosis and atherosclerosis. Current Interventional Cardiology Reports 1999 1 66
11. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., Aviram M., Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 11 2744 2752 2-s2.0-0031472264 (Pubitemid 28016017)
12. Aviram M., Fuhrman B., Sandler M., Pinder R. M., Wine flavonoids, LDL cholesterol oxidation and atherosclerosis. Wine: A Scientific explorAtion 2003 London, UK Taylor and Francis 140
13. Fuhrman B., Buch S., Vaya J., Belinky P. A., Coleman R., Hayek T., Aviram M., Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: In vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. American Journal of Clinical Nutrition 1997 66 2 267 275 2-s2.0-0030793620 (Pubitemid 27360324)
14. Aviram M., Vaya J., Fuhrman B., Packer L., Halliwel B., Ong C. N., Licorice root flavonoid antioxidants reduce LDL oxidation and attenuate cardiovascular diseases. Herbal Medicines: Molecular Basis of Biological Activity and Health 2004 chapter 27 NY, USA Marcel Dekker 595
15. 0) mice and reduce macrophage atherogenicity. Journal of Nutrition 2005 135 4 722 728 2-s2.0-16244393414 (Pubitemid 40464094)
16. Fuhrman B., Rosenblat M., Hayek T., Coleman R., Aviram M., Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. Journal of Nutrition 2000 130 5 1124 1131 2-s2.0-0034011401 (Pubitemid 30233257)
17. Langley P., Why a pomegranate? British Medical Journal 2000 321 7269 1153 1154 2-s2.0-0034605755
18. Aviram M., Martens S., Treutter D., Forkmann G., Polypyhenols from pomegranate juice, red wine and licorice root protect against lipids peroxidation and attenuate cardiovascular diseases. Polyphenols 2002 Germany Freising-Weihenstephan 158 Proceedings of the 20th International Conference on Polyphenols
19. Gil M. I., Tomas-Barberan F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry 2000 48 10 4581 4589 2-s2.0-0033788223 10.1021/jf000404a
20. Ben Nasr C., Ayed N., Metche M., Quantitative determination of the polyphenolic content of pomegranate peel. Zeitschrift fur Lebensmittel -Untersuchung und -Forschung 1996 203 4 374 378 2-s2.0-0030256012 (Pubitemid 126798349)
21. Aviram M., Monduzzi, Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. Proceedings of the 11th Biennal Meeting of the Society for Free Radical Research International July 2002 Paris, France MEDIMOND Inc 523
22. Aviram M., Aviram M., Fuhrman B., Rosenblat M., Pomegranate juice polyphenols decreases oxidative stress, low-density lipoprotein atherogenic modifications and atherosclerosis. Free Radical Research 2002 36 supplement 1 72 73
23. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., Hofman A., Rosenblat M., Volkova N., Presser D., Attias J., Hayek T., Fuhrman B., Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs under Experimental and Clinical Research 2002 28 2-3 49 62 2-s2.0-0036933448 (Pubitemid 36076888)
24. Cerdá B., Llorach R., Cerón J. J., Espín J. C., Tomás-Barberán F. A., Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. European Journal of Nutrition 2003 42 1 18 28 2-s2.0-0037219635 10.1007/s00394-003-0396-4 (Pubitemid 36286302)
25. Cerdá B., Cerón J. J., Tomás-Barberán F. A., Espín J. C., Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. Journal of Agricultural and Food Chemistry 2003 51 11 3493 3501 2-s2.0-0038284925 10.1021/jf020842c
26. Seeram N. P., Lee R., Heber D., Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clinica Chimica Acta 2004 348 1-2 63 68 2-s2.0-4444365417 10.1016/j.cccn.2004.04.029 (Pubitemid 39209002)
27. Pérez-Vicente A., Gil-Izquierdo A., García-Viguera C., In vitro gastrointestinal digestion study of pomegranate juice phenolic compounds, anthocyanins, and vitamin C. Journal of Agricultural and Food Chemistry 2002 50 8 2308 2312 2-s2.0-0037051508 10.1021/jf0113833 (Pubitemid 34275303)
28. Aviram M., Dornfeld L., Rosenblat M., Volkova N., Kaplan M., Coleman R., Hayek T., Presser D., Fuhrman B., Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. American Journal of Clinical Nutrition 2000 71 5 1062 1076 2-s2.0-0034013311 (Pubitemid 30230552)
29. Kaplan M., Hayek T., Raz A., Coleman R., Dornfeld L., Vaya J., Aviram M., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. Journal of Nutrition 2001 131 8 2082 2089 2-s2.0-0034900739 (Pubitemid 32720634)
30. De Nigris F., Williams-Ignarro S., Lerman L. O., Crimi E., Botti C., Mansueto G., D'Armiento F. P., De Rosa G., Sica V., Ignarro L. J., Napoli C., Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proceedings of the National Academy of Sciences of the United States of America 2005 102 13 4896 4901 2-s2.0-20144388620 10.1073/pnas.0500998102 (Pubitemid 40471550)
31. Sumner M. D., Elliott-Eller M., Weidner G., Daubenmier J. J., Chew M. H., Marlin R., Raisin C. J., Ornish D., Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. American Journal of Cardiology 2005 96 6 810 814 2-s2.0-24944514547 10.1016/j.amjcard.2005.05.026 (Pubitemid 41317656)
32. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., Volkova N., Presser D., Attias J., Liker H., Hayek T., Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clinical Nutrition 2004 23 3 423 433 2-s2.0-33748502306 10.1016/j.clnu.2003.10.002 (Pubitemid 38811681)
33. Davidson M. H., Maki K. C., Dicklin M. R., Feinstein S. B., Witchger M., Bell M., McGuire D. K., Provost J. C., Liker H., Aviram M., Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. American Journal of Cardiology 2009 104 7 936 942 2-s2.0-70249150742 10.1016/j.amjcard.2009.05.037
34. Seeram N. P., Aviram M., Zhang Y., Henning S. M., Feng L., Dreher M., Heber D., Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. Journal of Agricultural and Food Chemistry 2008 56 4 1415 1422 2-s2.0-40549091931 10.1021/jf073035s (Pubitemid 351364077)
35. Rosenblat M., Volkova N., Attias J., Mahamid R., Aviram M., Consumption of polyphenolic-rich beverages (mostly pomegranate and black currant juices) by healthy subjects for a short term increased serum antioxidant status, and the serum's ability to attenuate macrophage cholesterol accumulation. Food and Function 2010 1 1 99 109 2-s2.0-79951618330 10.1039/c0fo00011f
36. Rosenblat M., Hayek T., Aviram M., Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006 187 2 363 371 2-s2.0-33745495836 10.1016/j.atherosclerosis. 2005.09.006 (Pubitemid 43963016)
37. Rock W., Rosenblat M., Miller-Lotan R., Levy A. P., Elias M., Aviram M., Consumption of Wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. Journal of Agricultural and Food Chemistry 2008 56 18 8704 8713 2-s2.0-53649110742 10.1021/jf801756x
38. Fuhrman B., Volkova N., Aviram M., Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients. Nutrition 2010 26 4 359 366 2-s2.0-77349101573 10.1016/j.nut.2009.05.003
39. Aviram M., Rosenblat M., Billecke S., Erogul J., Sorenson R., Bisgaier C. L., Newton R. S., La Du B., Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biology and Medicine 1999 26 7-8 892 904 2-s2.0-0032921557 10.1016/S0891- 5849(98)00272-X (Pubitemid 29198362)
40. Khateeb J., Gantman A., Kreitenberg A. J., Aviram M., Fuhrman B., Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR- γ pathway. Atherosclerosis 2010 208 1 119 125 2-s2.0-73449098892 10.1016/j.atherosclerosis.2009.08.051
41. Aviram M., Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radical Research 2000 33 S85 S97 2-s2.0-0034525341 (Pubitemid 32055068)
42. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J., Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation 1995 91 9 2488 2496 2-s2.0-0028925078
43. Fuhrman B., Oiknine J., Aviram M., Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 1994 111 1 65 78 2-s2.0-0028001652 10.1016/0021-9150(94)90192-9 (Pubitemid 24330618)
44. Fuhrman B., Judith O., Keidar S., Ben-Yaish L., Kaplan M., Aviram M., Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radical Biology and Medicine 1997 23 1 34 46 2-s2.0-0031011549 10.1016/S0891-5849(96)00588-6 (Pubitemid 27217006)
45. Fuhrman B., Volkova N., Aviram M., Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 2002 161 2 307 316 2-s2.0-0036123993 10.1016/S0021-9150(01)00646-3 (Pubitemid 34219183)
46. Rozenberg O., Howell A., Aviram M., Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis 2006 188 1 68 76 2-s2.0-33746525640 10.1016/j.atherosclerosis.2005.10.027 (Pubitemid 44142537)
47. Aggarwal B. B., Shishodia S., Suppression of the nuclear factor- B activation pathway by spice-derived phytochemicals: reasoning for seasoning. Annals of the New York Academy of Sciences 2004 1030 434 441 2-s2.0-15044361086 10.1196/annals.1329.054 (Pubitemid 40378943)
48. Schubert S. Y., Neeman I., Resnick N., A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. The FASEB Journal 2002 16 14 1931 1933 2-s2.0-0036884292
49. Schubert S. Y., Lansky E. P., Neeman I., Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal of Ethnopharmacology 1999 66 1 11 17 2-s2.0-0032976772 10.1016/S0378-8741(98)00222-0 (Pubitemid 29305408)
50. Ng C. J., Wadleigh D. J., Gangopadhyay A., Hama S., Grijalva V. R., Navab M., Fogelman A. M., Reddy S. T., Paraoxonase 2 is aubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. Journal of Biological Chemistry 2001 276 48 44444 44449 2-s2.0-0035976903 10.1074/jbc.M105660200
51. Rosenblat M., Draganov D., Watson C. E., Bisgaier C. L., La Du B. N., Aviram M., Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 3 468 474 2-s2.0-0037339957 10.1161/01.ATV.0000059385.95664.4D (Pubitemid 36337224)
52. Ng C. J., Bourquard N., Grijalva V., Hama S., Shih D. M., Navab M., Fogelman A. M., Lusis A. J., Young S., Reddy S. T., Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. Journal of Biological Chemistry 2006 281 40 29491 29500 2-s2.0-33749544927 10.1074/jbc.M605379200 (Pubitemid 44536957)
53. Rosenblat M., Coleman R., Reddy S. T., Aviram M., Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1. Journal of Lipid Research 2009 50 5 870 879 2-s2.0-67649690455 10.1194/jlr.M800550-JLR200
54. Meilin E., Aviram M., Hayek T., Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice. Atherosclerosis 2010 208 2 390 395 2-s2.0-75049083347 10.1016/j.atherosclerosis. 2009.07.057
55. Shiner M., Fuhrman B., Aviram M., Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR γ and AP-1 pathway activation. Atherosclerosis 2007 195 2 313 321 2-s2.0-36048994061 10.1016/j.atherosclerosis.2007.01.007 (Pubitemid 350087961)
56. Rosenblat M., Volkova N., Aviram M., Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis 2010 212 1 86 92 2-s2.0-77956231001 10.1016/j.atherosclerosis.2010.04.039
57. Aviram M., Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. European Journal of Clinical Chemistry and Clinical Biochemistry 1996 34 8 599 608 2-s2.0-0029837209 (Pubitemid 26293746)
58. Steinberg D., Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 1997 272 34 20963 20966 2-s2.0-0030799043 10.1074/jbc.272.34.20963 (Pubitemid 27373946)
59. Goldstein J. L., Brown M. S., Regulation of the mevalonate pathway. Nature 1990 343 6257 425 430 2-s2.0-0025120211 10.1038/343425a0 (Pubitemid 20065229)
60. Brown M. S., Goldstein J. L., A receptor-mediated pathway for cholesterol homeostasis. Science 1986 232 4746 34 47 2-s2.0-0022549920 (Pubitemid 16037973)
61. Krieger M., The best of cholesterols, the worst of cholesterols: a tale of two receptors. Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4077 4080 2-s2.0-0032516013 10.1073/pnas.95.8.4077 (Pubitemid 28207864)
62. Fuhrman B., Volkova N., Aviram M., Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. Journal of Nutritional Biochemistry 2005 16 9 570 576 2-s2.0-23944519922 10.1016/j.jnutbio.2005.02.009 (Pubitemid 41188038)
63. Cullen P., Evidence that triglycerides are an independent coronary heart disease risk factor. American Journal of Cardiology 2000 86 9 943 949 2-s2.0-0034332715 10.1016/S0002-9149(00)01127-9
64. Lundberg B., Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 1985 56 1 93 110 2-s2.0-0021873187 (Pubitemid 15049652)
65. Aronis A., Madar Z., Tirosh O., Mechanism underlying oxidative stress-mediated lipotoxicity: Exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radical Biology and Medicine 2005 38 9 1221 1230 2-s2.0-15944425804 10.1016/j.freeradbiomed.2005.01.015 (Pubitemid 40445539)
66. Rosenblat M., Aviram M., Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis. Annals of Nutrition and Metabolism 2011 58 1 1 9 2-s2.0-78650882960 10.1159/000323096
67. Tzulker R., Glazer I., Bar-Ilan I., Holland D., Aviram M., Amir R., Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. Journal of Agricultural and Food Chemistry 2007 55 23 9559 9570 2-s2.0-36749040261 10.1021/jf071413n (Pubitemid 350205310)
68. Seeram N., Lee R., Hardy M., Heber D., Rapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry. Separation and Purification Technology 2005 41 1 49 55 2-s2.0-7444220592 10.1016/j.seppur.2004.04.003
69. Rosenblat M., Volkova N., Coleman R., Aviram M., Pomegranate byproduct administration to apolipoprotein E-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. Journal of Agricultural and Food Chemistry 2006 54 5 1928 1935 2-s2.0-33645452706 10.1021/jf0528207
70. 0) mice and in vitro in cultured macrophages and lipoproteins. Journal of Agricultural and Food Chemistry 2008 56 3 1148 1157 2-s2.0-39749177647 10.1021/jf071811q (Pubitemid 351300295)